HIGHLIGHTS
- who: Ermias Diro and colleagues from the Research Ethics Review Committee, thegrant agreement FL-0001526.038, have published the article: A randomized trial of AmBisome monotherapy and AmBisome and miltefosine combination to treat visceral leishmaniasis in HIV co-infected patients in Ethiopia, in the Journal: (JOURNAL) of January/17,/2019
- what: The authors report the results of a trial to assess the efficacy and safety of both the currently internationally recommended treatment of monotherapy and the new AmBisome-miltefosine combination regimen in Ethiopian patients. The results of this trial show that one course of treatment . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.